biolab ghk cu Glow Blend 70mg | Lab Tested GHK-CU – ND BioLabs

Hierarchy of Evidence: Level D (In vitro and rodent models)

Patients who are already managing the once-weekly injection cadence of Semaglutide or Tirzepatide and do not want to add daily injections are not good candidates for GHK-Cu, not because of any contraindication, but because they wont maintain the protocol consistently enough to see results

What Is the GHK-Cu Peptide

Preclinical work covers soft-tissue repair, blood-vessel formation, and GI-mucosa protection

Homeyer, N., Horn, A

These comparisons are notable because both vitamin C and retinoic acid are established, well-regarded ingredients in dermatological practice